Faes Farma dividend and valuation
Valuation
Faes Farma paid €0.13 per share in dividends over the last 12 months (yield 2.6%). Last ex-dividend date: July 2, 2026. The P/E ratio is 18.7. The average price target of 5 analysts is €5.56.
What would Faes Farma's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 16, 2026
Faes Farma compared with similar companies
Faes Farma's P/E (trailing 12 months): 18.7, in line with the median of a group of 10 similar companies (19.0).
| Metric | Faes Farma | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 18.7 | 19.0 | 17.7 – 25.4 | Middle |
| Forward P/E | 14.6 | 15.9 | 14.6 – 21.2 | Middle |
| EV/EBITDA | 15.2 | 12.9 | 9.75 – 14.9 | High |
| Price/book | 2.03 | 2.77 | 1.96 – 3.31 | Middle |
| Price/sales | 2.14 | 2.21 | 2.04 – 3.72 | Middle |
| Gross margin | 65.2% | 65.6% | 46.3% – 77.1% | Middle |
| Operating margin | 13.0% | 20.2% | 13.7% – 23.9% | Low |
| Net margin | 10.9% | 12.8% | 9.9% – 15.5% | Middle |
| ROE | 11.2% | 15.4% | 10.7% – 16.8% | Middle |
| Debt/equity | 0.58 | 0.36 | 0.23 – 0.67 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Faes Farma: valuation over time
On the latest fiscal year's earnings (2025), Faes Farma's P/E today is 19.8, above the median of its last 10 fiscal years (14.1; between 9.78 and 22.3 from 2016 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (2.6%) is below the median of the last 10 fiscal years (4.7%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | €5.16 | €0.25 | 20.3 | €0.13 | 2.5% |
| 2024 | €3.48 | €0.36 | 9.78 | €0.18 | 5.1% |
| 2023 | €3.16 | €0.30 | 10.7 | €0.16 | 4.9% |
| 2022 | €3.38 | €0.29 | 11.5 | €0.16 | 4.6% |
| 2021 | €3.35 | €0.27 | 12.4 | €0.21 | 6.2% |
| 2020 | €3.36 | €0.25 | 13.6 | €0.20 | 5.9% |
| 2019 | €4.81 | €0.23 | 20.6 | €0.17 | 3.5% |
| 2018 | €2.86 | €0.19 | 14.7 | €0.14 | 4.9% |
| 2017 | €2.83 | €0.16 | 17.7 | €0.02 | 0.7% |
| 2016 | €3.24 | €0.15 | 22.3 | €0.02 | 0.6% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- €1.58B
- Enterprise value
- €1.89B
- PEG
- 0.91
- EV/revenue
- 2.57
Profitability and growth
- ROA
- 5.0%
- ROIC
- 5.7%
- Revenue growth (year over year)
- 17.4%
- Earnings growth (year over year)
- 8.9%
Financial health
- Total cash
- €136.78M
- Total debt
- €449.29M
- Current ratio
- 2.63
- Quick ratio
- 1.66
- Piotroski F-Score
- 6.00
Dividends
- Annual dividend per share
- €0.13
- Dividend yield
- 2.6%
- Payout ratio
- 47.4%
- Ex-dividend date
- July 2, 2026
Analysts and estimates
- Average price target
- €5.56
- Median price target
- €5.50
- High price target
- €6.10
- Low price target
- €4.82
- Analysts with a price target
- 5
- Consensus
- Buy
- Forward EPS
- €0.35
- EPS estimate, current year
- €0.29
Shares and trading
- Beta
- 0.30
- Average volume
- 169.06K
- Shares outstanding
- 311.45M
- Float
- 218.33M
- Institutional ownership
- 15.7%
- Insider ownership
- 20.4%
